Clubs & Associations

Kevin C. Gorman, Ph.D. (’91), is a founder and previously served as chief operating officer after having served as executive vice president and chief business officer and senior vice president of business development of Neurocrine Biosciences. From 1990 until joining Neurocrine in 1993, Dr. Gorman was a principal of Avalon Medical Partners L.P., where he was responsible for the early-stage founding of Neurocrine and several other biotechnology companies, such as Onyx Pharmaceuticals, Metra Biosystems, IDUN and ARIAD Pharmaceuticals. He currently sits on the boards of the Biotechnology Innovation Organization and Xencor Inc. He received his Ph.D. in immunology and his MBA in finance from the University of California, Los Angeles, and undertook further postdoctoral training at The Rockefeller University.

Patty Maysent (’90) is chief executive officer of UC San Diego Health, the region's only academic health system, comprising UC San Diego Medical Center, Jacobs Medical Center, Shiley Eye Institute and Sulpizio Cardiovascular Center, as well as other primary and specialty practices located throughout Southern California. Appointed CEO in 2016, Maysent oversees a $1.7-billion annual operating budget and more than 9,000 employees.

During her time as CEO, Maysent has focused on enhancing UC San Diego Health’s reputation as a health care destination for complex specialty care and local, community-based care. She has been instrumental in the successful openings of a new hospital, an outpatient pavilion and multiple community clinics.

Previously, she was CEO of St. Jude Medical Center and served as a consultant for University of Southern California’s Keck Medical Center and Alliance HealthCare Services.

Maysent holds a bachelor’s degree in human biology from Stanford University and a master’s degree in business administration and public health from UCLA.

Kevin C. Gorman, Ph.D. (’91), is a founder and previously served as chief operating officer after having served as executive vice president and chief business officer and senior vice president of business development of Neurocrine Biosciences. From 1990 until joining Neurocrine in 1993, Dr. Gorman was a principal of Avalon Medical Partners L.P., where he was responsible for the early-stage founding of Neurocrine and several other biotechnology companies, such as Onyx Pharmaceuticals, Metra Biosystems, IDUN and ARIAD Pharmaceuticals. He currently sits on the boards of the Biotechnology Innovation Organization and Xencor Inc. He received his Ph.D. in immunology and his MBA in finance from the University of California, Los Angeles, and undertook further postdoctoral training at The Rockefeller University.